Download
1 / 13
160 likes | 225 Views
The global market for biologics drug discovery market reached nearly USD 56.6 billion in 2016 and is expected to reach USD 140.9 billion by 2024 at the CAGR of 12% over the forecast period.
E N D
Vision Value Visibility Report Code :HC 1285 2016-2024 Global Biologics Drug Discovery Market Outlook 2024: Global Opportunity & Growth Analysis, 2016-2024 99 Wall Street, Suite No:- 527, New York, NY 10005 United States of America +1-646-568-7747 +1-437-886-1181 Office No:- 504, 5th Floor, C-51, BSI Business Park, Sector-62, Noida, PIN:- 201301 India +44-203-318-6627 +91-120-473-0422, +91-844-785-9968 www.goldsteinresearch.com sales@goldsteinresearch.com Published By: Goldstein Research Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com
Executive Summary Sample Request Global Biologics Drug Discovery Market Share(%), By Region-2016-2024 Global Biologics Drug Discovery Market Size USD (Billion). 2016-2024 XX% CAGR: (2016-2024) Sample Source: Goldstein Research Source: Goldstein Research In 2016,High Throughput Screening accounted for the highest market share XX% in Biologics Drug Discovery Market WithXX%share in 2016, North America region dominated the collective Global Biologics Drug Discovery market Global Biologics Drug Discovery Market Share(%), By End User-2016 Global Biologics Drug Discovery Market Share(%), By Technology-2016 Global Biologics Drug Discovery Market Share(%), By Phase of Discovery-2016 Source: Goldstein Research Source: Goldstein Research Source: Goldstein Research Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com
Sample Request Key Findings Increasing presence of Contract Research Organizations • The global biologics drug discovery market was estimated to be USD XX billion in 2016 and is estimated to grow over USD XX billion by 2024. Introduction of targeted therapies coupled with rising adoption of patient centric personalized medicine is expected to fuel the demand for biologics drugs in the future • Geographically, biologics have registered near double digit annual growth rate, whereas, the pharmaceutical drugs registered only single digit annual growth rate, in the past five years. This double digit growth was largely fueled by the substantial investments of the major pharmaceutical companies, who realized the potential of the market quite early • The global biologics drug discovery market can be segmented based on the basis of phase of discovery into target identification, hit generation, lead identification & lead optimization. The major contributor towards the market in 2016 was the lead optimization phase. Based on the manufacture type, the market is segmented into in-house & outsourced. The in-house market for the global biologics drug discovery was estimated to be USD XX billion in 2016. The CAGR was highest for the out-sourced manufacturing • Biologics are expected to contribute 50% to the sales of the top 100 products during the forecast period. This will lead to increased investment in the global biologics drug discovery market in future. For instance, in 2016, among the most valued R&D projects were Roche' Ocrelizumab & Sanofi's Dupilumab. And in 2017, Ocrevus (Ocrelizumab) & Dupixient (dupilumab) were among the top 2 product launches so far • The market for the drug discovery of monoclonal antibody is expected to reach USD XX billion by 2024. The next contributing segment is recombinant proteins. Geographically, the largest contributor to the growth of the global biologics drug discovery market was found to be North America due to the presence of pharmaceutical companies involved in R&D of biologics Increasing investment in the biologics drug discovery Introduction of targeted therapies Global Biologics Drug Discovery Revenue (USD Billion) Asia-Pacific North America rising adoption of patient centric personalized medicine USD XX Billion 2016 USD XX Billion USD XX Billion 2024 USD XX Billion Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com
Overview of Discovery Process Sample Request 1. Selected Targets 7. Clinical Candidate mAb Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com
Global Biologics Drug Discovery Market Size (USD Billion) & Growth Analysis Global Biologics Drug Discovery Market Size (USD Billion)-2016-2024 Global Biologics Drug Discovery Market Y-O-Y Growth (%) Analysis-2016-2024 Sample Source: Goldstein Research Source: Goldstein Research • North America Biologics Drug Discovery Industry size is anticipated to expand at a compound annual growth rate of XX% during the forecast period i.e. 2016-2024. Further, Biologics Drug Discovery revenue increased from USD XX billion in 2015 to USD XX billion in 2016 • Novartis is adding jobs to its biologics manufacturing operations even as the Swiss company makes cuts across other parts of its global operations, including traditional manufacturing. Novartis’ cross-town rival Roche, for example, laid out plans in 2013 to invest nearly USD XX billion to beef up its biologics manufacturing operations across the globe. Eli Lilly recently moved forward with plans to expand a biologics plant in Ireland, with plans to add 130 jobs there • South Korea’s Samsung has even jumped into the fray with no prior experience in drug production, believing that its phone and chemical production experience would help it excel in the market Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com
Market Dynamics of Global Biologics Drug Discovery Market Sample Request Growth Drivers Growth Barriers General Trend Highly Complex Moderately Complex Waived Technology Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com
Global Biologics Drug Discovery Market Share(%) - By Product Type & Technology, 2016-2024 Key Findings Global Biologics Drug Discovery Market Share, By Technology, 2016-2024 • There are currently more than 1,500 biomolecules undergoing clinical trials, and the success rate for biologics has so far been over twice that of small-molecule products, with 13 percent of biopharma products that enter the Phase I trial stage going on to launch • Investing in biotech R&D has yielded better returns than the pharma-industry average. The current biologics-development pipeline supports an outlook of continued healthy growth. The number of biotech patents applied for every year has been growing at 25 percent annually • The success of the clinical pipeline will lead to an unprecedented number of new molecule launches, rising from a handful a few years ago to 10 to 15 annually, as biopharma products make up an increasing share of new approvals from the US Food and Drug Administration in the future 2024 2016 Sample Source: Goldstein Research Global Biologics Drug Discovery Market Y-O-Y Growth, By Product, 2016-2024 Global Biologics Drug Discovery Market Size (USD Billion), By Product-2016-2024 Source: Goldstein Research Source: Goldstein Research Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com
Global Biologics Drug Discovery (Billions) By Technology, 2016-2024 Sample Source: Goldstein Research Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com
North-America Biologics Drug Discovery Market Size (USD Billion) & Y-O-Y growth (%),2016-2024 North-America Biologics Drug Discovery Market Share By Product, 2016-2024 North-America Biologics Drug Discovery Market Size(USD Billion)-2016-2024 Sample XX% 2024 2016 CAGR: (2016-2024) Source: Goldstein Research Source: Goldstein Research North-America Biologics Drug Discovery Market Size (USD Million), By End User-2016-2024 North-America Biologics Drug Discovery Market Size (USD Millions), By Country-2016-2024 Source: Goldstein Research Source: Goldstein Research Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com
Sample Request About Us Connect With Us: Published By: Goldstein Research Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com
Vision Value Visibility Sample Request About Us Based in U.S., Goldstein Research is a young business consulting and market research firm with vast reach across America, Asia and parts of Europe and the Middle East. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions. With 30+ domain experts and 50+ employees working day and night to crunch numbers and bring out the best and detailed market reports and forecasts, we strive to enable you to foresee upcoming market challenges and develop a robust business model and strategies, which would add to your profitability and market visibility as a brand. Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear cut forecasts. Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear cut forecasts. Published By: Goldstein Research Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com
Vision Value Visibility Sample Request Contact Us: For Research & Sales Related Queries +1-646-568-7747 +1-437-886-1181 +44-203-318-6627 +91-120-473-0422, +91-844-785-9968 sales@goldsteinresearch.com Corporate Office: 99 Wall Street, Suite No:- 527, New York, NY 10005 United States of America Office No:- 504, 5th Floor, C-51, BSI Business Park, Sector-62, Noida, PIN:- 201301 India www.goldsteinresearch.com Published By: Goldstein Research Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com
Sample Request Thank you Connect With Us: Published By: Goldstein Research Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com
